Inhibition by rifampin of the anticoagulant effect of phenprocoumon.
D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D001777:Blood Coagulation / Q000187:drug effects; D003374:Coumarins / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use; D013166:Spondylitis / Q000188:drug therapy; D013997:Time Factors; D014394:Tuberculosis, Osteoarticular / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000925:Anticoagulants; D001593:Benzyl Compounds; D003374:Coumarins; D012293:Rifampin